Estrogen receptor positive breast cancers in BRCA1 mutation carriers: clinical risk factors and pathologic features

INTRODUCTION: Most breast cancers that occur in women with germline BRCA1 mutations are estrogen receptor-negative (ER-) and also typically lack expression of progesterone receptor (PR) and HER2 overexpression. We undertook a study to assess the clinical factors that predict for an estrogen receptor...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Tung, Nadine, Wang, Yihong, Collins, Laura C, Kaplan, Jennifer, Li, Hailun, Gelman, Rebecca, Comander, Amy H, Gallagher, Bridget, Fetten, Katharina, Krag, Karen, Stoeckert, Kathryn A, Legare, Robert D, Sgroi, Dennis, Ryan, Paula D, Garber, Judy E, Schnitt, Stuart J
Format: Artigo
Sprache:Inglês
Veröffentlicht: BioMed Central 2010
Schlagworte:
Research article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2880433/
https://ncbi.nlm.nih.gov/pubmed/20149218
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/bcr2478
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge